GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK…
SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted type 2 diabetes
GlycoMantra has been awarded a two-year SBIR grant from the NIAID (NIH) to investigate COVID-19-impacted type 2 diabetes.
